These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration. Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636 [TBL] [Abstract][Full Text] [Related]
13. Smear-negative, culture-positive pulmonary tuberculosis among patients with chronic cough in Cotonou, Benin. Affolabi D; Akpona R; Odoun M; Alidjinou K; Wachinou P; Anagonou S; Gninafon M; Trébucq A Int J Tuberc Lung Dis; 2011 Jan; 15(1):67-70. PubMed ID: 21276299 [TBL] [Abstract][Full Text] [Related]
14. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure. Ambreen A; Jamil M; Rahman MAU; Mustafa T BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021 [TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar. Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476 [TBL] [Abstract][Full Text] [Related]
16. Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis. Takasaka N; Seki Y; Fujisaki I; Uchiyama S; Matsubayashi S; Sato A; Yamanaka Y; Odashima K; Kazuyori T; Seki A; Takeda H; Ishikawa T; Kuwano K BMC Pulm Med; 2020 Nov; 20(1):287. PubMed ID: 33160360 [TBL] [Abstract][Full Text] [Related]
17. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts. Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194 [TBL] [Abstract][Full Text] [Related]
18. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850 [TBL] [Abstract][Full Text] [Related]
19. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting. Huerga H; Varaine F; Okwaro E; Bastard M; Ardizzoni E; Sitienei J; Chakaya J; Bonnet M PLoS One; 2012; 7(12):e51336. PubMed ID: 23284681 [TBL] [Abstract][Full Text] [Related]
20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]